Within your prior big pharma employers, AI is now a core competitive capability as it has shortened target identification and optimized molecule design. As building world-class AI drug-discovery ...
Project Trialblazer prioritizes reducing IND review timelines, but its impact on sponsor behavior may be limited when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results